Literature DB >> 33635951

Enhancing Military Burn- and Trauma-Related Acute Kidney Injury Prediction Through an Automated Machine Learning Platform and Point-of-Care Testing.

Hooman H Rashidi1, Amy Makley2, Tina L Palmieri3, Samer Albahra1, Julia Loegering1, Lei Fang4, Kensuke Yamaguchi4, Travis Gerlach5, Dario Rodriquez6, Nam K Tran1.   

Abstract

CONTEXT.—: Delayed recognition of acute kidney injury (AKI) results in poor outcomes in military and civilian burn-trauma care. Poor predictive ability of urine output (UOP) and creatinine contribute to the delayed recognition of AKI. OBJECTIVE.—: To determine the impact of point-of-care (POC) AKI biomarker enhanced by machine learning (ML) algorithms in burn-injured and trauma patients. DESIGN.—: We conducted a 2-phased study to develop and validate a novel POC device for measuring neutrophil gelatinase-associated lipocalin (NGAL) and creatinine from blood samples. In phase I, 40 remnant plasma samples were used to evaluate the analytic performance of the POC device. Next, phase II enrolled 125 adults with either burns that were 20% or greater of total body surface area or nonburn trauma with suspicion of AKI for clinical validation. We applied an automated ML approach to develop models predicting AKI, using a combination of NGAL, creatinine, and/or UOP as features. RESULTS.—: Point-of-care NGAL (mean [SD] bias: 9.8 [38.5] ng/mL, P = .10) and creatinine results (mean [SD] bias: 0.28 [0.30] mg/dL, P = .18) were comparable to the reference method. NGAL was an independent predictor of AKI (odds ratio, 1.6; 95% CI, 0.08-5.20; P = .01). The optimal ML model achieved an accuracy, sensitivity, and specificity of 96%, 92.3%, and 97.7%, respectively, with NGAL, creatinine, and UOP as features. Area under the receiver operator curve was 0.96. CONCLUSIONS.—: Point-of-care NGAL testing is feasible and produces results comparable to reference methods. Machine learning enhanced the predictive performance of AKI biomarkers including NGAL and was superior to the current techniques.
© 2021 College of American Pathologists.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33635951     DOI: 10.5858/arpa.2020-0110-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  Novel application of automated machine learning with MALDI-TOF-MS for rapid high-throughput screening of COVID-19: a proof of concept.

Authors:  Nam K Tran; Taylor Howard; Ryan Walsh; John Pepper; Julia Loegering; Brett Phinney; Michelle R Salemi; Hooman H Rashidi
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

2.  Prediction of Tuberculosis Using an Automated Machine Learning Platform for Models Trained on Synthetic Data.

Authors:  Hooman H Rashidi; Imran H Khan; Luke T Dang; Samer Albahra; Ujjwal Ratan; Nihir Chadderwala; Wilson To; Prathima Srinivas; Jeffery Wajda; Nam K Tran
Journal:  J Pathol Inform       Date:  2022-01-20

3.  Comparative performance of two automated machine learning platforms for COVID-19 detection by MALDI-TOF-MS.

Authors:  Hooman H Rashidi; John Pepper; Taylor Howard; Karina Klein; Larissa May; Samer Albahra; Brett Phinney; Michelle R Salemi; Nam K Tran
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.